Avantor, Inc. $AVTR Stock Bought by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP lifted its holdings in Avantor, Inc. (NYSE:AVTR) by 2,047.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 176,112 shares of the company’s stock after buying an additional 167,912 shares during the quarter. Fulcrum Asset Management LLP’s holdings in Avantor were worth $2,684,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Elevation Wealth Partners LLC grew its position in shares of Avantor by 72.3% during the 3rd quarter. Elevation Wealth Partners LLC now owns 2,803 shares of the company’s stock valued at $42,000 after buying an additional 1,176 shares during the last quarter. Root Financial Partners LLC bought a new position in Avantor in the third quarter worth about $57,000. Nisa Investment Advisors LLC lifted its holdings in Avantor by 40.8% in the third quarter. Nisa Investment Advisors LLC now owns 4,938 shares of the company’s stock worth $74,000 after acquiring an additional 1,431 shares during the last quarter. IFP Advisors Inc lifted its holdings in Avantor by 901.4% in the second quarter. IFP Advisors Inc now owns 5,858 shares of the company’s stock worth $58,000 after acquiring an additional 5,273 shares during the last quarter. Finally, State of Wyoming acquired a new position in Avantor in the second quarter valued at approximately $74,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of NYSE:AVTR opened at $15.59 on Wednesday. The stock has a market cap of $10.56 billion, a price-to-earnings ratio of 19.40, a PEG ratio of 7.20 and a beta of 0.95. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.89 and a quick ratio of 1.27. Avantor, Inc. has a 12 month low of $7.26 and a 12 month high of $17.45. The stock’s 50 day moving average price is $15.64 and its 200 day moving average price is $11.36.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, October 28th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Avantor had a return on equity of 9.79% and a net margin of 5.08%. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company posted $0.22 EPS. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. Equities research analysts anticipate that Avantor, Inc. will post 0.82 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. UBS Group assumed coverage on Avantor in a report on Wednesday, September 9th. They set a “neutral” rating and a $16.00 target price for the company. Evercore set a $17.00 price target on Avantor in a report on Wednesday, October 28th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $17.00 price target on shares of Avantor in a report on Thursday, October 29th. Barclays boosted their price objective on Avantor from $15.00 to $16.00 and gave the company an “underweight” rating in a research report on Thursday, October 29th. Finally, Wolfe Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, July 30th. Two equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $14.77.

About Avantor

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.